Precision motion systems specialist Allient (NASDAQ:ALNT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.2% year on year to $153.8 million. Its non-GAAP profit of $0.80 per share was 30.6% above analysts’ consensus estimates.
Is now the time to buy Allient? Find out by accessing our full research report, it’s free.
Allient (ALNT) Q2 CY2026 Highlights:
- Revenue: $153.8 million vs analyst estimates of $145.7 million (10.2% year-on-year growth, 5.5% beat)
- Adjusted EPS: $0.80 vs analyst estimates of $0.61 (30.6% beat)
- Adjusted EBITDA: $23.72 million vs analyst estimates of $20.12 million (15.4% margin, 17.9% beat)
- Operating Margin: 10.2%, in line with the same quarter last year
- Free Cash Flow was -$18.31 million, down from $22.38 million in the same quarter last year
- Backlog: $298 million at quarter end, up 26% year on year
- Market Capitalization: $1.58 billion
Company Overview
Founded in 1962, Allient (NASDAQ:ALNT) develops and manufactures precision and specialty-controlled motion components and systems.
Revenue Growth
Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, Allient grew its sales at a decent 8% compounded annual growth rate. Its growth was slightly above the average industrials company and shows its offerings resonate with customers.
We at StockStory place the most emphasis on long-term growth, but within industrials, a half-decade historical view may miss cycles, industry trends, or a company capitalizing on catalysts such as a new contract win or a successful product line. Allient’s recent performance shows its demand has slowed as its revenue was flat over the last two years. 
This quarter, Allient reported year-on-year revenue growth of 10.2%, and its $153.8 million of revenue exceeded Wall Street’s estimates by 5.5%.
Looking ahead, sell-side analysts expect revenue to grow 6.3% over the next 12 months. While this projection implies its newer products and services will fuel better top-line performance, it is still below the sector average.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
Operating Margin
Operating margin is a key measure of profitability. Think of it as net income - the bottom line - excluding the impact of taxes and interest on debt, which are less connected to business fundamentals.
Allient was profitable over the last five years but held back by its large cost base. Its average operating margin of 7.4% was weak for an industrials business.
On the plus side, Allient’s operating margin rose by 3 percentage points over the last five years, as its sales growth gave it operating leverage.
In Q2, Allient generated an operating margin profit margin of 10.2%, in line with the same quarter last year. This indicates the company’s cost structure has recently been stable.
Earnings Per Share
We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.
Allient’s EPS grew at 16.9% compounded annual growth rate over the last five years, higher than its 8% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.
Diving into the nuances of Allient’s earnings can give us a better understanding of its performance. As we mentioned earlier, Allient’s operating margin was flat this quarter but expanded by 3 percentage points over the last five years. This was the most relevant factor (aside from the revenue impact) behind its higher earnings; interest expenses and taxes can also affect EPS but don’t tell us as much about a company’s fundamentals.
Like with revenue, we analyze EPS over a more recent period because it can provide insight into an emerging theme or development for the business.
For Allient, its two-year annual EPS growth of 9.6% was lower than its five-year trend. We hope its growth can accelerate in the future.
In Q2, Allient reported adjusted EPS of $0.80, up from $0.57 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects Allient’s full-year EPS to grow 19.4% from $2.44 to $2.91.
Key Takeaways from Allient’s Q2 Results
It was good to see Allient beat analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this was a solid print. The stock traded up 3.1% to $96.02 immediately after reporting.
Indeed, Allient had a rock-solid quarterly earnings result, but is this stock a good investment here? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here (it’s free).